In vivo echocardiographic assessment of left ventricular function in transgenic and gene-targeted mice

Trends in Cardiovascular Medicine

Volumn 7, Issue 4, 1997, Pages 129-134

  Hoit, Brian D ^a   Walsh, Richard A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; DIAGNOSTIC VALUE; DOPPLER ECHOCARDIOGRAPHY; GENE TARGETING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE CONTRACTILITY; M MODE ECHOCARDIOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

EID: 0030948931     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00003-0     Document Type: Review

References (27)

1. Appleton CP, Hatle LK, Popp RL Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol. 12:1988;426-440.
2. Barbee RW, Berry BD, Re RN, Murgo JP Microsphere and dilution techniques for the determination of blood flows and volumes in conscious mice. Am J Physiol. 263:1992;R728-R733.
3. Borow KM, Green LH, Grossman W, Braunwald E Left ventricular end-systolic stress shortening and stress length relations in humans. Am J Cardiol. 50:1982;1301-1308.
4. Chien KR Perspectives series: molecular medicine in genetically engineered animals. Genes and physiology: molecular physiology in genetically engineered animals. J Clin Invest. 97:1996;901-909.
5. Dorn GW II, Robbins J, Ball N, Walsh RA Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. Am J Physiol. 267:1994;H400-H405.
6. Feigenbaum H: 1994. Instrumentation. In Feigenbaum H, ed. Echocardiography, 5th ed. Malvern, PA, Lea & Febiger, pp 1-67.
7. Field LJ Transgenic mice in cardiovascular research. Annu Rev Physiol. 55:1993;97-114.
8. Gardin JM, Siri FM, Kitsis RN, Edwards JG, Leinwand L Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ Res. 76:1995;907-914.
9. Grupp IL, Subramaniam A, Hewett TE, Robbins J, Grupp G Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations. Am J Physiol. 265:1993;H1401-H1410.
10. Gunteski-Hamblin AM, Song G, Walsh RAet al. Annexin VI overexpression in transgenic mouse heart alters cardiac myocyte contractile function, calcium dynamics and heart pathology. Am J Physiol. 270:1996;H1091-H1100.
11. Hartley CJ, Michael LH, Entman ML Noninvasive measurement of ascending aortic blood velocity in mice. Am J Physiol. 268:1995;H499-H505.
12. Hoit BD, Khoury SF, Kranias EGet al. In vivo echocardiographic detection of enhanced left ventricular filling in gene targeted mice with phospholamban deficiency. Circ Res. 77:1995;632-637.
13. Hoit BD, Khan ZU, Pawloski-Dahm CM, Walsh RA In vivo, determination of left ventricular shortening and wall stress relationship in normal mice. Am J Physiol. 272:1997;H1047-H1052.
14. sα overexpression. Circ Res. 97:1996;533-539.
15. Kadambi VJ, Ponniah S, Harrer JMet al. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest. 97:1996;533-539.
16. Lenihan DJ, Gerson MC, Hoit BD, Walsh RA Mechanisms, diagnosis, and treatment of diastolic heart failure. Am Heart J. 130:1995;153-166.
17. Manning WJ, Wei JY, Katz SE, Litwin SE, Douglas PS In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. Am J Physiol. 266:1994;H1672-H1675.
18. Michael LH, Entman ML, Hartley CJet al. Myocardial ischemia and reperfusion: a murine model. Am J Physiol. 269:1995;H2147-H2154.
19. Milano CA, Allen LF, Rockman HAet al. Enhanced myocardial function in transgenic mice overexpressing the β2-adrenergic receptor. Science. 264:1994;582-586.
20. Nishimura RA, Abel MD, Hatle LK, Tajik AJ Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. II: Clinical studies. Mayo Clin Proc. 64:1989;181-204.
21. Nishimura RA, Housmans PR, Hatle LK, Tajik AJ Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. I: Physiologic and pathophysiologic features. Mayo Clin Proc. 64:1989;71-81.
22. Peterson KL, Skloven D, Lundbrook P, Uther JB, Ross JR Jr. Comparison of isovolumic and ejection phase indices of myocardial performance in man. Circulation. 49:1974;1088-1101.
23. Rockman HA, Ono S, Ross RSet al. Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci USA. 91:1994;2694-2698.
24. Sabbah HN, Khaja BS, Brymer JFet al. Noninvasive evaluation of left ventricular performance based on peak aortic blood acceleration measured with a continuous-wave Doppler velocity meter. Circulation. 74:1986;323-329.
25. Tanaka N, Dalton N, Mao Let al. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation. 94:1996;1109-1117.
26. Wallmeyer K, Wann LS, Sagar KBet al. The influence of preload and heart rate on Doppler echocardiographic indexes of left ventricular performance: comparison with invasive indexes in an experimental preparation. Circulation. 74:1986;181-186.
27. Weiss JL, Shapiro EP, Buchalter MB, Beyar R Magnetic resonance imaging as a non-invasive standard for the quantitative evaluation of left ventricular mass, ischemia, and infarction. Ann NY Acad Sci. 601:1990;95-106.